Pure alumina ceramic has been, in clinical, used in orthopaedics since 1971 and currently up to five million components have been implanted. Alumina offers advantages like stability, biocompatibility and low wear, however it has limited strength. Applications are limited by design considerations. Engineers in biomaterials have worked on improving the performances of the material by optimising the manufacturing process. To fulfil surgeons and patients increasingly exacting requirements, ceramists have also developed a new ceramic composite, the alumina matrix composite (AMC). This material combines the great principles of reinforcement of ceramics with its tribological qualities and presents a better mechanical resistance than alumina. The examination of the tribological situation of AMC, especially under challenging condition of hydrothermal ageing, shows the aptitude of this material in wear applications. The US Food and Drug Administration has approved the ceramic ball heads articulating against polyethylene inserts. Since its introduction, more than 65,000 ball heads and 40,000 inserts of the Alumina Matrix Composite have been implanted. With a six-year clinical experience, no complication has been reported to the manufacturer. Improved toughness and the excellent wear, makes it a potentially more flexible alternative to the more traditional alumina for hip prostheses.
Read full abstract